- Home
- SCOR vs LSTA Comparison
SCOR vs LSTA Comparison
Compare SCOR & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- LSTA
- Stock Information
- Founded
- SCOR 1999
- LSTA 1980
- Country
- SCOR United States
- LSTA United States
- Employees
- SCOR N/A
- LSTA N/A
- Industry
- SCOR Business Services
- LSTA Misc Health and Biotechnology Services
- Sector
- SCOR Consumer Discretionary
- LSTA Health Care
- Exchange
- SCOR Nasdaq
- LSTA Nasdaq
- Market Cap
- SCOR 37.1M
- LSTA 20.9M
- IPO Year
- SCOR 2007
- LSTA N/A
- Fundamental
- Price
- SCOR $7.36
- LSTA $2.35
- Analyst Decision
- SCOR
- LSTA Strong Buy
- Analyst Count
- SCOR 0
- LSTA 2
- Target Price
- SCOR N/A
- LSTA $23.50
- AVG Volume (30 Days)
- SCOR 161.0K
- LSTA 42.8K
- Earning Date
- SCOR 11-04-2025
- LSTA 11-11-2025
- Dividend Yield
- SCOR N/A
- LSTA N/A
- EPS Growth
- SCOR N/A
- LSTA N/A
- EPS
- SCOR N/A
- LSTA N/A
- Revenue
- SCOR $358,513,000.00
- LSTA $1,070,000.00
- Revenue This Year
- SCOR $3.45
- LSTA N/A
- Revenue Next Year
- SCOR $2.59
- LSTA N/A
- P/E Ratio
- SCOR N/A
- LSTA N/A
- Revenue Growth
- SCOR N/A
- LSTA N/A
- 52 Week Low
- SCOR $4.39
- LSTA $1.87
- 52 Week High
- SCOR $10.18
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- SCOR 49.11
- LSTA 44.38
- Support Level
- SCOR $7.13
- LSTA $2.26
- Resistance Level
- SCOR $7.86
- LSTA $2.61
- Average True Range (ATR)
- SCOR 0.45
- LSTA 0.13
- MACD
- SCOR -0.14
- LSTA -0.02
- Stochastic Oscillator
- SCOR 19.17
- LSTA 25.01
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.